This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Combination of Donepezil and Gabapentin for Behavioral Disorders in Alzheimer’s Disease

Carlo Dallocchio, Carlo Buffa, and Paolo Mazzarello

Published: June 30, 2000

Article Abstract

Letter to the Editor

Sir: Behavioral symptoms are very frequent in patients with Alzheimer’s disease, and management of these symptoms is a primary goal of therapy. Several drugs may be used with benefit, including atypical neuroleptics, selective serotonin reuptake inhibitors, anticonvulsants, tacrine, and the newer acetylcholinesterase inhibitors such as donepezil, recently indicated for the symptomatic treatment of Alzheimer’s disease. Indeed, there are conflicting reports in the literature about the action of donepezil in behavioral disorders associated with Alzheimer’s disease, with some authors reporting a benefit and others reporting a worsening of the symptoms.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: